 Home > Medical News >

Medical Research Articles

BMS stops developing new antiviral drugs and cancels 100 related positions

 Time of Update: 2015-06-29

trastuzumab brand name study time space drug test strips antiviral malaria treatment drugs

Bristol Myers Squibb said on June 25 that it would stop developing new antiviral drugs and would remove 100 related positions The company said its early projects on hepatitis B and HIV would also be t
Merrimack company mm-398, an authorized partner of Taiwan smart engine biotechnology, has obtained the FDA's new drug priority review qualification

 Time of Update: 2015-06-25

malaria treatment drugs metastatic gastric cancer transdermal drug delivery future project manager pharmaceutical associates inc

Pharmaengine, Inc announced on June 25 that Merrimack pharmaceutical company, the authorized partner of the company, was informed by the US Food and Drug Administration (US FDA) to cooperate with Zhiq
Synthetic pharmaceutical chemicals class 1.1 new drug - Disodium l-ornidazole phosphate - approved clinical trial

 Time of Update: 2015-06-24

benadryl drug class act drug buspirone drug test herb drug interactions modafinil drug class

Announcement of synthetic pharmaceutical industry (832077) on June 23 According to the statement, the company's declared new chemical drug of class 1.1, "disodium l-ornidazole phosphate and disodium l
Geli applied for the first clinical trial of full oral hepatitis C treatment scheme independently developed in China

 Time of Update: 2015-06-24

tryptophan food sources science food chain barbecue food send food mail processed food meaning

China's innovative drug development company, today (June 24th), announced that the clinical trial application of the all oral anti interferon chronic hepatitis C treatment scheme was accepted by the S
China rejects the patent application of salvdi

 Time of Update: 2015-06-21

gilead drugs office manager salary international patent new world investor new indian currency

Recently, a propaganda organization in the United States said that China rejected the patent application for Geely de hepatitis C, which may lead other countries to consider rejecting the patent for t
Chinese Traditional Medicine Association and the Forbidden City work together to develop palace medicine

 Time of Update: 2015-06-18

mood stabilizer medicine allergy medicine target statin cholesterol medicine pristiq medicine creon medicine

On June 15, the Palace Museum signed a cooperation agreement with the China Association of traditional Chinese medicine The two sides will carry out long-term and extensive academic exchanges and coop
CFDA approved two new indications

 Time of Update: 2015-06-18

new world key pulmonary embolism deep vein thrombosis risk management process pulmonary embolism flying cancer risk assessment

Recently, Bayer healthcare announced that CFDA has approved two new indications for the treatment of adult deep vein thrombosis (DVT), reducing the risk of DVT recurrence and pulmonary embolism after
Remidazolam besylate, a new anesthetic drug of humanwell pharmaceutical, 1.1, has been successfully approved

 Time of Update: 2015-06-17

aleve drug what nootropic drug plan drug hemolyzed blood sample food drug interactions list

According to the information on June 17 on the website of the State Food and Drug Administration (CFDA), the acceptance status of humanwell Pharmaceutical (600079) class 1.1 new drug rimazazolam besyl
Levocetirizine hydrochloride granules, a class 5 new drug of Kangzhi pharmaceutical, has obtained the production approval

 Time of Update: 2015-06-16

board directors salary 1 4 dioxane clopidogrel drug class mpa drug drug discovery process

In the afternoon of June 16, Kangzhi pharmaceutical released a notice that the company recently received the registration approval document of levocetirizine hydrochloride granules approved and issued
Tifental, a new class 1.1 drug of Guizhou bailing chemical, has been granted a US patent

 Time of Update: 2015-06-15

modafinil mechanism action principles environmental science enzalutamide mechanism action co benefits product data sheet

Guizhou bailing (002424) announced in the evening of June 14 that the company's new chemical 1.1 drug, tefentai (original Y101), had recently obtained a US patent Tifentai US patent application No is
CDE drug review weekly report (June 7, 2015 to June 13, 2015)

 Time of Update: 2015-06-15

cancer injection treatment erythropoietin side effects triclosan side effects armor thyroid side effects science safety goggles

1 In the review week (2015.6.7-2015.6.13), there are 90 drugs in the review status (calculated according to the acceptance number, excluding supplementary application and review), including 84 chemica
Huiyang new life drug, a subsidiary of Kangenbei, has been approved for phase I clinical trial in the United States

 Time of Update: 2015-06-12

levodopa drug class hf acquisition co llc mdpv drug air duster drug opdivo drug

Kangenbei (600572) announced in the evening of June 11 that Sichuan Huiyang life Engineering Co., Ltd., a joint-stock subsidiary of the company, obtained the phase I clinical trial license document fr
Nabil hydrochloride, a class 3.1 high blood pressure drug of Fuan Pharmaceutical Co., Ltd., entered the site for examination this month and is expected to be approved within this year

 Time of Update: 2015-06-12

spiriva drug class stage ii hypertension oxybutynin drug class hydrocodone drug class diamond making process

According to the information on the website of CFDA on June 12, the new chemical drug of Fuan Pharmaceutical (300194 SZ) category 3.1 will enter the drug registration and production site for inspectio
Hebei Aoxing Group Pharmaceutical Co., Ltd. announced the approval of tiridine, an anaesthetic and pain relief drug, to be listed on the New York Stock Exchange

 Time of Update: 2015-06-11

valium drug interactions zolpidem drug class new author disa drug testing butalbital drug

Aoxing Pharmaceutical Co., Ltd announced the approval of new drugs to be listed on the New York Stock Exchange on June 9 local time Aoxing Pharmaceutical Co., Ltd held a press conference on the New Yo
Huahai Pharmaceutical's New Drug Valsartan Tablets Approved for Sale in the U.S.

 Time of Update: 2015-06-11

dopa used treat product research drug product database drug food interaction pharmaceutical company

Huahai pharmaceutical announced in the evening of June 11 that the company had received a notice from the U.S Food and Drug Administration (FDA) that the company had approved the Anda (American generi
CDE drug review report in May 2015

 Time of Update: 2015-06-11

bcr abl mutation caffeine chemical name b12 injection name phenobarbital generic name molecule 1 perfume

Key points in May: the drug registration fee rose sharply at the end of May, but the number of applications did not decrease Guangdong Dongguang applied for 1.1 diabetes drug, Guangdong Dongguang's fi
CDE Drug Evaluation Weekly Report (2015.6.1-2015.6.5)

 Time of Update: 2015-06-10

diclofenac sodium tablets naltrexone drug class anti topoisomerase antibody cancer drug names salt 4

In the approval process, 16 drugs have entered the approval process this week, including 12 chemicals, 1 Traditional Chinese medicine and 3 biological products for prevention The key information is as
Four parts of institutional innovation of Shanghai Pharmaceutical Research Institute make researchers become "hundred million yuan households" more quickly

 Time of Update: 2015-06-09

buspirone drug optimum transfer account all chemist all posters celebrex drug

Under the background of leading generic drugs and scarcity of original drugs in China, Shanghai Institute of pharmaceutical research, Chinese Academy of Sciences has recently produced new drug achieve
Kangyuan pharmaceutical actively distributes research and development of biological drugs

 Time of Update: 2015-06-09

biggest pharmaceutical companies japanese pharmaceutical companies company caulking companies near pharmaceutical industry worth

Kangyuan Pharmaceutical (600557 SH), a leading Chinese patent medicine innovation enterprise, plans to further expand its product line to biopharmaceuticals At present, the group is actively distribut
Application for production of 1.1 new hypoglycemic drug of Hengrui medicine

 Time of Update: 2015-06-09

calcium phosphate food food safety programs janssen research development stock food protein production high

1.1 class 1 new drug regolitine is applied for production, and its long-term income is expected to exceed 1 billion yuan After apatinib and 19K, the class 1.1 new oral hypoglycemic drug regolitine of

Go to Page

Medical Research Articles

BMS stops developing new antiviral drugs and cancels 100 related positions

Merrimack company mm-398, an authorized partner of Taiwan smart engine biotechnology, has obtained the FDA's new drug priority review qualification

Synthetic pharmaceutical chemicals class 1.1 new drug - Disodium l-ornidazole phosphate - approved clinical trial

Geli applied for the first clinical trial of full oral hepatitis C treatment scheme independently developed in China

China rejects the patent application of salvdi

Chinese Traditional Medicine Association and the Forbidden City work together to develop palace medicine

CFDA approved two new indications

Remidazolam besylate, a new anesthetic drug of humanwell pharmaceutical, 1.1, has been successfully approved

Levocetirizine hydrochloride granules, a class 5 new drug of Kangzhi pharmaceutical, has obtained the production approval

Tifental, a new class 1.1 drug of Guizhou bailing chemical, has been granted a US patent

CDE drug review weekly report (June 7, 2015 to June 13, 2015)

Huiyang new life drug, a subsidiary of Kangenbei, has been approved for phase I clinical trial in the United States

Nabil hydrochloride, a class 3.1 high blood pressure drug of Fuan Pharmaceutical Co., Ltd., entered the site for examination this month and is expected to be approved within this year

Hebei Aoxing Group Pharmaceutical Co., Ltd. announced the approval of tiridine, an anaesthetic and pain relief drug, to be listed on the New York Stock Exchange

Huahai Pharmaceutical's New Drug Valsartan Tablets Approved for Sale in the U.S.

CDE drug review report in May 2015

CDE Drug Evaluation Weekly Report (2015.6.1-2015.6.5)

Four parts of institutional innovation of Shanghai Pharmaceutical Research Institute make researchers become "hundred million yuan households" more quickly

Kangyuan pharmaceutical actively distributes research and development of biological drugs

Application for production of 1.1 new hypoglycemic drug of Hengrui medicine